|
|
Volumn 10, Issue 17, 2005, Pages 1132-
|
|
UK government guidance on Alzheimer's drugs postponed
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARIPIPRAZOLE;
ATYPICAL ANTIPSYCHOTIC AGENT;
DONEPEZIL;
GALANTAMINE;
MEMANTINE;
OLANZAPINE;
RISPERIDONE;
RIVASTIGMINE;
ZIPRASIDONE;
ALZHEIMER DISEASE;
COST BENEFIT ANALYSIS;
DRUG APPROVAL;
DRUG COST;
DRUG EFFICACY;
DRUG FATALITY;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG MECHANISM;
GOVERNMENT REGULATION;
HUMAN;
LONG TERM CARE;
NOTE;
PSYCHOSIS;
QUALITY OF LIFE;
SIDE EFFECT;
UNITED KINGDOM;
|
|
EID: 24944500022
PISSN: 13596446
EISSN: None
Source Type: Journal
DOI: 10.1016/S1359-6446(05)03586-5 Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|
